Alabama Court Rejects Verdicts in Drug Price Cases
Oct 19, 2009 Birmingham, Ala.
The Alabama Supreme Court reversed $274 million in judgments entered in favor of the state against three pharmaceutical companies - AstraZeneca PLC, Novartis AG, and GlaxoSmithKline PLC - and directed that judgment be entered in the pharmaceutical companies' favor. The state had alleged that the drug companies overcharged the State for prescription drugs for Medicaid recipients.
Novartis was represented in the trial and appeal by Chris King, Harlan Prater, Craig Rosler, and Nikaa Jordan of Lightfoot, Franklin & White, LLC.
Click here to read The Am Law Litigation Daily article about the reversal.